Carregant...
A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme()
COVID-19 has affected millions of people. Although many drugs are in use to combat disease, there is not any sufficient treatment yet. Having critical role in propagation of the novel coronavirus (SARS-CoV-2) works Main Protease up into a significant drug target. We have performed a molecular dockin...
Guardat en:
| Publicat a: | Journal of the Indian Chemical Society |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Indian Chemical Society. Published by Elsevier B.V.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056978/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jics.2021.100041 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|